尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the full record of transactions filed by Klencke Barbara, Directeur Médical. Director active across 3 companies, notably Sierra Oncology, Inc.. Aggregated, 6 filings have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €73k. History available since 1 July 2022. The latest transaction was disclosed on 16 June 2026 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 条申报中的 6 条
Barbara Klencke is the Chief Medical Officer of Sierra Oncology, Inc. She is responsible for the company's medical strategy, including the development of new treatments and clinical research. Her role is essential for ensuring that the company remains at the forefront of innovation in the healthcare sector.